Filing Details

Accession Number:
0001055726-22-000041
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-17 16:32:21
Reporting Period:
2022-05-13
Accepted Time:
2022-05-17 16:32:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1055726 Inovio Pharmaceuticals Inc. INO Surgical & Medical Instruments & Apparatus (3841) 330969592
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1669080 B. David Weiner 660 W. Germantown Pike
Suite 110
Plymouth Meeting PA 19462
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-13 18,000 $0.00 901,625 No 4 M Direct
Common Stock Disposition 2022-05-16 9,000 $1.95 892,625 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2022-05-13 18,000 $0.00 18,000 $0.00
Common Stock Restricted Stock Unit Acquisiton 2022-05-16 19,000 $0.00 19,000 $0.00
Common Stock Common Stock Options Acquisiton 2022-05-16 28,000 $0.00 28,000 $1.89
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
19,000 No 4 A Direct
28,000 2032-05-16 No 4 A Direct
Footnotes
  1. Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 13, 2022.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Reporting person intends to use the proceeds of this sale to pay taxes resulting from the recent vesting of Restricted Stock Units granted by the issuer.
  3. Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 16, 2023.
  4. This grant was made pursuant to the issuer's non-employee director compensation policy.
  5. Options to vest 100% on May 16, 2023.